EMA looks into falsified Ozempic with German and Austrian origins

The Eu­ro­pean Med­i­cines Agency has been no­ti­fied by rel­e­vant na­tion­al au­thor­i­ties that pre-filled pens false­ly la­beled as the type 1 di­a­betes med­i­cine Ozem­pic have been iden­ti­fied at whole­salers in the EU and the UK.

The fal­si­fied pens have la­bels in Ger­man and orig­i­nat­ed from whole­salers in Aus­tria and Ger­many, the EMA said Wednes­day.

“There is no ev­i­dence that any fal­si­fied pens have been dis­pensed to pa­tients from le­gal phar­ma­cies, and there are no re­ports of harm to pa­tients in re­la­tion to the fal­si­fied med­i­cine,” EMA said.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.